High Tide Reports Record Quarterly Distribution of 7.6 Tonnes of Medical Cannabis Through Remexian Pharma GmbH, Accelerating German Market Leadership

CALGARY, AB, May 6, 2026 /PRNewswire/ - High Tide Inc. ("High Tide" or the "Company") (Nasdaq: HITI) (TSXV: HITI) (FSE: 2LYA), the high-impact, retail-forward enterprise built to deliver real-world value across every component of cannabis, announced today preliminary tonnage data from its 51%-owned German subsidiary, Remexian Pharma GmbH ("Remexian"), for the second fiscal quarter ended April 30, 2026. During the quarter, Remexian sold 7.6 tonnes of medical cannabis into the German market, representing the highest quarterly distribution volume in its history.